HPLC, UHPLC

Analysis of Residual Pharmaceutical and Personal Care Products in River Waters via UHPLC-MS/MS

Author: Wilhad M. Reuter and Jamie Foss on behalf of PerkinElmer

Free to read

This article has been unlocked and is ready to read.

Download

Pharmaceutical and Personal Care Products (PPCPs) are an emerging environmental concern and include prescription medications, over-the-counter medications, sunscreens, lotions, soaps, and insect repellent [1-4]. These commonly encountered products can enter the environment through various sources, including municipal waste water.  Identifying and quantifying the presence of the chemical pollutants that these products contribute in surface waters, particularly in rivers and lakes, has been a growing focus.

The analytical challenge is that PPCPs encompass a wide variety of chemical classes/types and are typically present at parts per million (µg/mL) or even parts per trillion (pg/mL) concentrations in surface waters [1-4]. Therefore, developing an optimal analytical method, one that provides effective chromatographic separation, as well as optimal analyte sensitivity, is a daunting task. This often requires some compromises to be made in accommodating all the analytes that one intends to quantify.
In this study we demonstrate the application of UHPLC-MSMS for the separation, detection and quantitation of 31 PPCPs in river waters. UHPLC-MSMS is ideally suited for such an analysis, as UHPLC provides for optimal chromatographic separation, while MSMS provides for optimal sensitivity and specificity. MSMS also allows for positive ID confirmation via an analyte’s unique combination of mass transitions and ion ratio.

Experimental Hardware/Software
For the chromatographic separations, a PerkinElmer® LX50 UHPLC System was used with a PerkinElmer® QSightTM 220 MS/MS detector.  All instrument control, analysis and data processing was performed using the Simplicity 3Q™ software platform.

Method parameters
The LC and MS/MS method/source parameters are shown in Tables 1, 2 and 3, respectively.
Solvents and Standards    
All solvents, reagents, and diluents used were HPLC-grade or better. The PPCP standards (listed in Table 2) were purchased as follows: Pharmaceuticals Mix #1 and #2 (PharmMix1 and Pharmmix2, respectively) were purchased from Restek, Bellefonte, PA; all the other PPCPs were purchased from Sigma-Aldrich® Inc., Milwaukee, WI.


Standard and Sample Preparation
For all liquid standards, a 1-µg/mL (ppm) stock standard solution was prepared as follows: 500 µL of both PharmMix1 and PharmMix2 (200 µg/mL each, in methanol) were added to a 100-mL volumetric flask. To this flask, 100 µL each of codeine, cotinine, diazepam, butalbital and tramadol (1000 µg/mL each, in methanol) were also added. The flask was then filled to volume with 10% methanol/water.
For all solid standards, 10 mg of each was added to a 1000-mL volumetric flask, which was then filled to volume with methanol (required for solubility of some analytes). This solution was stirred for 20 minutes, to allow all of the solid standards to dissolve completely, and then further diluted 10-fold with water, providing a stock standard solution of 1 µg/mL
The two stock standard solutions were then combined 1:1, to make a standard mix containing 0.5 µg/mL of each analyte. This was further diluted 1:1 with water, providing a working standard mix (WS) containing 0.25 µg/mL of each analyte in 5% methanol/water.  The WS was serially diluted with 5% methanol/water to make calibration standards ranging from 0.025 to 250 ng/mL (ppb).
Two river water samples were collected from local rivers, one from the Hudson River in Cold Spring, New York, and one from the Housatonic River in Stratford, Connecticut. Each sample was first filtered using a 0.45-µm nylon filter and then 50 µl of the filtered sample was directly injected on column for analysis.
To check for any carryover, a 5% methanol/water blank was injected after both the standard set and the samples.
All standards and samples were submitted for LC-MS/MS analysis and run in triplicate.

Results and Discussion
Figure 1 shows the total ion chromatogram (TIC) of the WS containing all analysed PPCPs, of which close to 20 are well resolved. The remaining PPCPs were further resolved via their unique MW transitions.
Represented by six of the analysed PPCPs, the overlaid MRM (multiple reaction monitoring) chromatograms of eight replicate injections are shown in Figure 2, demonstrating exceptional repeatability.
Figure 3 shows the calibration plots for six representative PPCPs. The R2 values for the 31 analytes ranged from 0.9944 to 0.99989. These were based upon at least 5 calibration levels, dependent on analyte response.
For matrix matching, it would have been preferred to run the calibration set with river water as the diluent; however, PPCP-‘clean’ river water was unavailable.
The calculated LOQs for the 31 analysed PPCPs are provided in Table 4, with most values in the low ppt range. This was based upon the S/N calculated from the lowest calibrant used for each analyte. The lowest calibrant depended on the individual response for each analyte. The spread reflects the diversity of the compounds found among PPCPs.
Samples of Housatonic and Hudson River water were then analysed for PPCPs. Their respective total ion chromatographic (TIC) profiles are shown in Figure 4.  The annotations refer to peak retention times.
Figure 5 shows the MRM chromatograms of the quantifiable PPCPs found in the two river waters, as labeled.
As shown in Table 5, ppt (pg/mL) levels of tramadol, cotinine, ciprofloxacin, 1,7-dimethylxanthine, diphenhydramine and diclofenac were found in both river samples.  Quantifiable levels of doxycycline and fluoxetine were only found in the Hudson River sample, while fluoxetine was found at a trace level in the Housatonic River sample. Acetaminophen, sulfamethoxazole and gemfibrozil were also found in the Hudson River sample, but only at trace levels.  None of the other analysed PPCPs were detected in either river sample.
To check for possible analyte carryover or background interference, a blank sample, consisting of 5% methanol/water was also run in triplicate, both after the calibration set and after the samples.  No carryover was observed for any of the analytes.
For analyte ID confirmation, the qualifier/quantifier ion ratios were used, with a 20% tolerance limit.  For many analytes, these were applicable down to the lowest calibrant concentration (25 ppt). An example of ion ratios for diphenhydramine at the individual calibration levels, as well as for actual samples, is shown in Table 6. For those analytes with significantly weaker qualifier ions, the ratios were applicable down to low ppb levels.  For butalbital, fluoxetine and triclosan, a suitable/robust qualifier transition was not identified. 
Conclusions
• A reverse phase LC-MS/MS method has been developed and demonstrated to be effective for the analysis of 31 PPCPs in river waters, using a PerkinElmer LX50 UHPLC/QSight 220 MS/MS system.
• The described method/procedure provides a fast, reliable direct-injection PPCP analysis in under 7 minutes, with a sample turn-around time of 11 minutes and LOQs at low ppt levels for most analytes.

References
1. NYC Environmental Protection, 2010 Occurrence of Pharmaceutical and Personal Care Products (PPCPs) in Source Water of the New York City Water Supply, August 19, 2011;
http://www.nyc.gov/html/dep/pdf/quality/nyc_dep_2010_ppcpreport.pdf
2. New Hampshire Department of Environmental services, Environmental Health Sheet,
Pharmaceuticals and Personal Care Products in Drinking Water and Aquatic Environments - Answers to Frequently Asked Questions; 2010
https://www.des.nh.gov/organization/commissioner/pip/factsheets/dwgb/documents/dwgb-22-28.pdf
3. Ebele, A.J., Abou-Elwafa Abdallah, M., Harrad, S., Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment, Emerging Contaminants, Volume 3, Issue 1, March 2017, Pages 1-16
4. Daughton, C.G., Environ. Impact Assess. Rev. 24 (2004) 711.
 

Free to read

This article has been unlocked and is ready to read.

Download


Events

SCM-11

Jan 20 2025 Amsterdam, Netherlands

Medlab Middle East

Feb 03 2025 Dubai, UAE

China Lab 2025

Feb 05 2025 Guangzhou, China

PITTCON 2025

Mar 01 2025 Boston, MA, USA

H2 Forum

Mar 04 2025 Berlin, Germany

View all events